Production (Stage)
Compass Therapeutics, Inc.
CMPX
$2.37
-$0.045-1.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.63M | -15.03M | -10.48M | -13.08M | -10.79M |
| Total Depreciation and Amortization | 364.00K | 359.00K | 465.00K | 466.00K | 463.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.54M | 1.97M | 1.92M | 1.39M | 1.63M |
| Change in Net Operating Assets | 521.00K | 3.54M | -2.96M | 462.00K | -5.19M |
| Cash from Operations | -13.21M | -9.16M | -11.05M | -10.75M | -13.89M |
| Capital Expenditure | -18.00K | 0.00 | -44.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.61M | 15.37M | 29.06M | 6.48M | -4.10M |
| Cash from Investing | 11.59M | 15.37M | 29.02M | 6.48M | -4.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 18.11M |
| Repurchase of Common Stock | -815.00K | -96.00K | 0.00 | 0.00 | -136.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 2.00K | -2.00K | 1.00K | -544.00K |
| Cash from Financing | -815.00K | -94.00K | -2.00K | 1.00K | 17.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.44M | 6.11M | 17.97M | -4.27M | -554.00K |